Mesoblast Return on Equity (ROE) Growth & History (MESO)
Mesoblast's return on equity was −9.86% for fiscal 2026.
View full Mesoblast company overviewMesoblast annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-06-30 | −9.86% | +9.09 pp |
| 2025 | 2025-06-30 | −18.95% | −1.04 pp |
| 2024 | 2024-06-30 | −17.91% | −1.51 pp |
| 2023 | 2023-06-30 | −16.40% | +0.54 pp |
| 2022 | 2022-06-30 | −16.94% | +0.54 pp |
| 2021 | 2021-06-30 | −17.48% | −2.35 pp |
| 2020 | 2020-06-30 | −15.13% | +2.36 pp |
| 2019 | 2019-06-30 | −17.49% | −10.85 pp |
| 2018 | 2018-06-30 | −6.64% | +8.06 pp |
| 2017 | 2017-06-30 | −14.70% | — |
Mesoblast quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-03-31 | −3.70% | +0.25 pp |
| Q1 2023 | 2022-09-30 | −3.31% | +0.66 pp |
| Q3 2022 | 2022-03-31 | −3.96% | +0.70 pp |
| Q1 2022 | 2021-09-30 | −3.97% | +0.54 pp |
| Q3 2021 | 2021-03-31 | −4.65% | −1.57 pp |
| Q1 2021 | 2020-09-30 | −4.51% | −3.37 pp |
| Q4 2020 | 2020-06-30 | −6.29% | −2.07 pp |
| Q3 2020 | 2020-03-31 | −3.09% | +1.78 pp |
| Q2 2020 | 2019-12-31 | −5.04% | −0.44 pp |
| Q1 2020 | 2019-09-30 | −1.15% | — |
| Q4 2019 | 2019-06-30 | −4.22% | — |
| Q3 2019 | 2019-03-31 | −4.87% | — |
| Q2 2019 | 2018-12-31 | −4.60% | — |
Mesoblast return on equity trends
Over the last five fiscal years, Mesoblast's return on equity increased from −17.48% to −9.86%, a change of +7.61 percentage points. The latest reported quarter, Q3 2023, shows −3.70%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mesoblast source filings ↗